PreprintAll rights reservedbioRxiv
Implementation and Evaluation of Marker Rescue and qPCR Assays for Detection of Replication-Competent Retrovirus in Gene Therapy Products
- 1Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. Cur
Related
- First-in-human trial in Burkinabe adults and children of replication-competent, genetically attenuated PfSPZ-LARC2 Vaccine for malaria
- Improving the detection, assessment, management and prevention of delirium in palliative care units (the DAMPen-Delirium II study): protocol for an implementation-to-target Type III hybrid effectiveness-implementation cluster randomised-controlled trial, economic evaluation and process evaluation of the Creating Learning Environments for Compassionate Care-Palliative (CLECC-Pal) implementation strategy.
- What are the implementation lessons from a high-volume cataract screening and surgical programme? A mixed-methods implementation evaluation in Sierra Leone
- Design, implementation, and evaluation of a comprehensive educational program for microbiology laboratory personnel and graduate students in teaching hospitals
- Implementation evaluation of a Massachusetts pilot program designed to reduce overdose deaths among Black and Latino men returning from incarceration
BibTeX
@misc{ebrahimiyan2026implementation,
title = {{Implementation and Evaluation of Marker Rescue and qPCR Assays for Detection of Replication-Competent Retrovirus in Gene Therapy Products}},
author = {H. Ebrahimiyan and A. Sayadmanesh and H. Baharvand and M. Basiri},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.27.762168},
url = {https://www.biorxiv.org/content/10.64898/2026.10.27.762168v1},
}
RIS
TY - UNPB
TI - Implementation and Evaluation of Marker Rescue and qPCR Assays for Detection of Replication-Competent Retrovirus in Gene Therapy Products
AU - H. Ebrahimiyan
AU - A. Sayadmanesh
AU - H. Baharvand
AU - M. Basiri
PY - 2026
DA - 2026/10/27
PB - bioRxiv
DO - 10.64898/2026.10.27.762168
UR - https://www.biorxiv.org/content/10.64898/2026.10.27.762168v1
ER -